...
| Dataset wrap |
|---|
|
| Rowcaps |
|---|
| Rows 1-2: | Show the baseline CMR ejection fraction measurements for participant 101 at VISIT 1. | | Row 3: | Shows the baseline NTProbTest for participant 101 at VISIT 1. | | Rows 4-5: | Show the CMR ejection fraction measurements for participant 101 at VISIT 6. | | Row 6: | Shows the NTProbTest for participant 101 at VISIT 6. |
|
| Dataset2 |
|---|
| | Row | STUDYID | USUBJID | ASEQ | TRT01P | ITTFL | BSABASE | PARAM | PARAMCD | PARAMN | AVAL | AVISIT | AVISITN | VISIT | ADT | ABLFL | BASE | CHG | PCHG | CHGCAT1 | CHGCAT2 | AGE | AGEU | SEX | SRCDOM | SRCSEQ |
|---|
| 1 | DMD-EFLGE | DMD-EFLGE-101 | 1 | Treatment A | Y | 0.65 | Left Ventricular Ejection Fraction, Calculated (%) | LVEFC | 1 | 67 | Visit 1 (Month 1Baseline) | 1 | VISIT 1 | 16MAY2022 | Y | 67 |
|
|
|
| 8 | YEARS | M | CV | 3 | | 2 | DMD-EFLGE | DMD-EFLGE-101 | 2 | Treatment A | Y | 0.65 | Right Ventricular Ejection Fraction, Calculated (%) | RVEFC | 2 | 74 | Visit 1 (Month 1Baseline) | 1 | VISIT 1 | 16MAY2022 | Y | 74 |
|
|
|
| 8 | YEARS | M | CV | 7 | | 3 | DMD-EFLGE | DMD-EFLGE-101 | 3 | Treatment A | Y | 0.65 | N-Terminal ProB-type Natriuretic Peptide (IU/L) | BNPPRONT | 3 | 40 | Visit 1 (Baseline) | 1 | VISIT 1 | 16MAY2022 | Y | 40 |
|
|
|
| 8 | YEARS | M | LB | 1 | | 4 | DMD-EFLGE | DMD-EFLGE-101 | 4 | Treatment A | Y | 0.65 | Left Ventricular Ejection Fraction, Calculated (%) | LVEFC | 1 | 60 | Visit 6 (Month 121 Year) | 6 | VISIT 6 | 01JUN2023 |
| 67 | -7 | -10.447761 | Decline >=10.0 |
| 8 | YEARS | M | CV | 11 | | 5 | DMD-EFLGE | DMD-EFLGE-101 | 5 | Treatment A | Y | 0.65 | Right Ventricular Ejection Fraction, Calculated (%) | RVEFC | 2 | 61 | Visit 6 (Month 121 Year) | 6 | VISIT 6 | 01JUN2023 |
| 74 | -13 | -17.567568 | Decline >=10.0 |
| 8 | YEARS | M | CV | 15 | | 6 | DMD-EFLGE | DMD-EFLGE-101 | 6 | Treatment A | Y | 0.65 | N-Terminal ProB-type Natriuretic Peptide (IU/L) | BNPPRONT | 3 | 900 | Visit 6 (Month 121 Year) | 6 | VISIT 6 | 01JUN2023 |
| 40 | 860 | 2,150 |
|
| 8 | YEARS | M | LB | 2 |
|
|
...
| Dataset wrap |
|---|
|
| Dataset2 |
|---|
| | Row | STUDYID | USUBJID | ASEQ | TRT01P | ITTFL | BSABASE | BNPPRONT | BNPCHG | PARAM | PARAMCD | PARAMN | AVAL | AVISIT | AVISITN | VISIT | ADT | ABLFL | BASE | CHG | PCHG |
|---|
TRT01P | ITTFL | AGE | AGEU | SEX | SRCDOM | SRCSEQ |
|---|
| 1 | DMD-EFLGE | DMD-EFLGE-101 | 1 | Treatment A | Y | 0.65 | 40 |
| Left Ventricular Ejection Fraction, Calculated (%) | LVEFC | 1 | 67 | Visit 1 ( |
Month 1| Baseline) | 1 | VISIT 1 | 16MAY2022 | Y | 67 |
Treatment AY |
|
| 8 | YEARS | M | CV | 3 | | 2 | DMD-EFLGE | DMD-EFLGE-101 | 2 | Treatment A | Y | 0.65 | 40 |
| Right Ventricular Ejection Fraction, Calculated (%) | RVEFC | 2 | 74 | Visit 1 ( |
Month 1| Baseline) | 1 | VISIT 1 | 16MAY2022 | Y | 74 |
Treatment A | Y |
|
| 8 | YEARS | M | CV | 7 | | 3 | DMD-EFLGE | DMD-EFLGE-101 | 3 | Treatment A | Y | 0.65 | 900 | 2150 | Left Ventricular Ejection Fraction, Calculated (%) | LVEFC | 1 | 60 | Visit 6 ( |
Month 12| 1 Year) | 6 | VISIT 6 | 01JUN2023 |
| 67 | -7 | -10.447761 |
Treatment A | Y | 8 | YEARS | M | CV | 11 | | 4 | DMD-EFLGE | DMD-EFLGE-101 | 4 | Treatment A | Y | 0.65 | 900 | 2150 | Right Ventricular Ejection Fraction, Calculated (%) | RVEFC | 2 | 61 | Visit 6 ( |
Month 12| 1 Year) | 6 | VISIT 6 | 01JUN2023 |
| 74 | -13 | -17.567568 |
Treatment A | Y |
|
ADCVEF Analysis Dataset
The ADCVEF dataset includes tests pertinent to this analysis, those for which CVTESTCD is equal to "LVEF_C" or "RVEF_C". The relationship dataset RELREC illustrates the relationship between datasets.
...